Oppenheimer & Co’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,745
| Closed | -$473K | – | 1446 |
|
|
2024
Q1 | $473K | Buy |
+1,745
| New | +$417K | 0.01% | 1011 |
|
|
2023
Q1 | – | Sell |
-1,486
| Closed | -$324K | – | 1394 |
|
|
2022
Q4 | $324K | Buy |
+1,486
| New | +$325K | 0.01% | 1057 |
|
|
2022
Q1 | – | Sell |
-1,635
| Closed | -$616K | – | 1491 |
|
|
2021
Q4 | $616K | Buy |
1,635
+178
| +12% | +$69.2K | 0.01% | 961 |
|
|
2021
Q3 | $601K | Sell |
1,457
-5
| -0.3% | -$2.08K | 0.01% | 942 |
|
|
2021
Q2 | $541K | Buy |
1,462
+34
| +2% | +$11.4K | 0.01% | 999 |
|
|
2021
Q1 | $414K | Sell |
1,428
-1,159
| -45% | -$322K | 0.01% | 1040 |
|
|
2020
Q4 | $646K | Sell |
2,587
-3
| -0.1% | -$714 | 0.01% | 791 |
|
|
2020
Q3 | $587K | Sell |
2,590
-23
| -0.9% | -$4.77K | 0.01% | 755 |
|
|
2020
Q2 | $456K | Buy |
2,613
+545
| +26% | +$87K | 0.01% | 833 |
|
|
2020
Q1 | $261K | Sell |
2,068
-1,062
| -34% | -$159K | 0.01% | 944 |
|
|
2019
Q4 | $478K | Sell |
3,130
-40
| -1% | -$5.54K | 0.01% | 851 |
|
|
2019
Q3 | $420K | Hold |
3,170
| – | – | 0.01% | 860 |
|
|
2019
Q2 | $450K | Sell |
3,170
-84
| -3% | -$11.4K | 0.01% | 854 |
|
|
2019
Q1 | $473K | Sell |
3,254
-47
| -1% | -$6.17K | 0.01% | 847 |
|
|
2018
Q4 | $374K | Sell |
3,301
-249
| -7% | -$31.2K | 0.01% | 850 |
|
|
2018
Q3 | $478K | Buy |
3,550
+863
| +32% | +$107K | 0.01% | 883 |
|
|
2018
Q2 | $302K | Buy |
2,687
+11
| +0.4% | +$1.19K | 0.01% | 1061 |
|
|
2018
Q1 | $286K | Buy |
+2,676
| New | +$288K | 0.01% | 1081 |
|
|
2014
Q2 | – | Sell |
-4,209
| Closed | -$254K | – | 1419 |
|
|
2014
Q1 | $254K | Buy |
+4,209
| New | +$245K | 0.01% | 1117 |
|
Other funds holding CRL
MG
SCA
